Transaction DateRecipientSharesTypePriceValue
15th January 2021Pharma Ventures Pty Ltd Mayne2,240,488Other acquisition or disposition$0.00
15th July 2020Pharma Ventures Pty Ltd Mayne3,189,688Other acquisition or disposition$0.00
2nd December 2019Garrison J. Hasara13,500Open or private purchase$0.07$945.00
15th January 2019Pharma Ventures Pty Ltd Mayne362,121Other acquisition or disposition$0.00
Hedge Path Pharmaceuticals
Hedge Path Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

HedgePath Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company. It discovers, develops and plans to commercialize therapeutics for patients with cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.

Ticker: HPPI
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1042418
Employees: 2
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags